24Q1业绩点评:归母净利润1.01亿元处于业绩预告区间上沿,归母净利率再创新高
Shanxi Jinbo Bio-Pharmaceutical (832982) 信达证券·2024-04-24 12:30
| --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...